Omada Health, Inc.
OMDA
$18.32
$0.442.46%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 42.00% | 58.08% | 49.47% | 48.92% | 56.61% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 42.00% | 58.08% | 49.47% | 48.92% | 56.61% |
| Cost of Revenue | 27.28% | 40.01% | 35.43% | 28.62% | 29.95% |
| Gross Profit | 52.64% | 67.00% | 57.80% | 62.30% | 83.88% |
| SG&A Expenses | 29.49% | 29.24% | 32.04% | 33.77% | 19.08% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 30.73% | 31.75% | 30.54% | 28.23% | 19.35% |
| Operating Income | 43.06% | 146.21% | 70.52% | 56.72% | 53.34% |
| Income Before Tax | 68.56% | 162.53% | 65.55% | 50.33% | 50.19% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 68.56% | 162.53% | 65.55% | 50.33% | 50.19% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 68.56% | 162.53% | 65.55% | 50.33% | 50.19% |
| EBIT | 43.06% | 146.21% | 70.52% | 56.72% | 53.34% |
| EBITDA | 53.66% | 181.21% | 84.18% | 66.25% | 58.13% |
| EPS Basic | 95.60% | 108.57% | 95.35% | 82.71% | 54.71% |
| Normalized Basic EPS | 95.60% | 108.56% | 98.43% | 82.70% | 54.71% |
| EPS Diluted | 95.60% | 107.78% | 95.35% | 82.71% | 54.71% |
| Normalized Diluted EPS | 95.60% | 107.77% | 98.43% | 82.70% | 54.71% |
| Average Basic Shares Outstanding | 615.00% | 630.08% | 640.34% | 187.24% | 9.98% |
| Average Diluted Shares Outstanding | 615.00% | 703.95% | 640.34% | 187.24% | 9.98% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |